7KE Stock Overview
Manufactures and sells regenerative fertilizer solutions to support a farm system in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Replenish Nutrients Holding Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.027 |
| 52 Week High | CA$0.072 |
| 52 Week Low | CA$0.023 |
| Beta | 1.19 |
| 11 Month Change | -10.74% |
| 3 Month Change | -29.07% |
| 1 Year Change | -44.58% |
| 33 Year Change | -85.78% |
| 5 Year Change | n/a |
| Change since IPO | -75.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7KE | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 11.8% | 1.3% | 0.8% |
| 1Y | -44.6% | 4.5% | 2.0% |
Return vs Industry: 7KE underperformed the German Chemicals industry which returned 4.5% over the past year.
Return vs Market: 7KE underperformed the German Market which returned 2% over the past year.
Price Volatility
| 7KE volatility | |
|---|---|
| 7KE Average Weekly Movement | 29.4% |
| Chemicals Industry Average Movement | 4.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 7KE's share price has been volatile over the past 3 months.
Volatility Over Time: 7KE's weekly volatility (29%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Neil Wiens | replenishnutrients.com |
Replenish Nutrients Holding Corp. manufactures and sells regenerative fertilizer solutions to support a farm system in Canada. The company operates through Fertilizer and Power segments. Its regenerative fertilizers enhance overall soil function and biology while providing valuable plant-available nutrients farmers rely upon for healthy crops.
Replenish Nutrients Holding Corp. Fundamentals Summary
| 7KE fundamental statistics | |
|---|---|
| Market cap | €4.84m |
| Earnings (TTM) | -€825.89k |
| Revenue (TTM) | €8.71m |
0.6x
P/S Ratio-5.9x
P/E RatioIs 7KE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7KE income statement (TTM) | |
|---|---|
| Revenue | CA$12.77m |
| Cost of Revenue | CA$11.39m |
| Gross Profit | CA$1.38m |
| Other Expenses | CA$2.59m |
| Earnings | -CA$1.21m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0085 |
| Gross Margin | 10.78% |
| Net Profit Margin | -9.48% |
| Debt/Equity Ratio | 20.1% |
How did 7KE perform over the long term?
See historical performance and comparison